Webinar: Community Update on the New INSPIRE DUCHENNE Clinical Study of SGT-003

Community Webinar: Solid Biosciences’ INSPIRE DUCHENNE Update and Study ExpansionПодробнее

Industry Update: Solid BiosciencesПодробнее

Webinar: Solid Biosciences Presents Safety & Efficacy Update (March 2021)Подробнее

Webinar: Ataluren Update with PTCПодробнее

Webinar: Edgewise Therapeutics - A Novel Approach to Protect Muscle in Duchenne & Becker (Oct 2022)Подробнее

Community Webinar: Transforming the Treatment Paradigm for DuchenneПодробнее

[Webinar] Santhera Update to the Duchenne Community - May 2019Подробнее

Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study ExpansionПодробнее

Duchenne UK Webinar: DMD Hub and Clinical Trial UpdateПодробнее

[Webinar] Results from Phase I/II HOPE Clinical Trial of CAP-1002 - April 2017Подробнее

Webinar: Santhera Pharmaceuticals Duchenne Drug Development Update (March 2021)Подробнее

Webinar: RGX-202 - AFFINITY DUCHENNE Pivotal Program and Functional DataПодробнее

[Webinar] Vamorolone (VBP15) Clinical Trials in Duchenne - January 2017Подробнее

[Webinar] HOPE-2 Duchenne Clinical Trial – Capricor – July 2018Подробнее

Community Webinar Series 2021: Advancements in Duchenne Drug Development and FDA Approved TherapiesПодробнее

Webinar: Dyne Therapeutics Update on DYNE-251 (July 2022)Подробнее

[Webinar] Vamorolone Clinical Trials in Duchenne - January 2019Подробнее

[Webinar] PolarisDMD: Phase 3 Clinical Trial of Edasalonexent, a Novel NF-kB Inhibitor - Nov 2018Подробнее

[Webinar] Translarna® (ataluren) Development Update - January 2019Подробнее